AWM
IRWD icon

Ariadne Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ariadne Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1K Buy
12,564
+340
+3% +$1.39K 0.02% 245
2025
Q4 		$56.4K Sell
12,224
-17
-0.1% -$44 0.02% 257
2025
Q3 		$41.3K Sell
12,241
-648
-5% -$671 0.02% 243
2025
Q2 		$14K Buy
+12,889
New +$10.1K 0.01% 229

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ariadne Wealth Management's IRWD Position: Q1 2026 in Review

Ariadne Wealth Management increased its Ironwood Pharmaceuticals (IRWD) stake by 2.8% in Q1 2026, buying an estimated $1.39K and bringing the position to 12,564 shares worth $44.1K. The position accounts for 0.02% of the portfolio, ranked #245.

Ariadne Wealth Management first reported a position in IRWD in Q2 2025 and has held it in 4 quarters since. The position peaked at $56.4K in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Ariadne Wealth Management held 12,564 shares of Ironwood Pharmaceuticals worth $44.1K as of Q1 2026.
  • Ariadne Wealth Management bought 340 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.39K.
  • Ironwood Pharmaceuticals made up 0.02% of Ariadne Wealth Management's portfolio in Q1 2026, its #245 holding.
  • Ariadne Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Ariadne Wealth Management's Ironwood Pharmaceuticals position peaked at $56.4K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.